NEWS: JULY 2007

-07/13/2007-

FDA orders Idenix Pharmaceuticals Inc. stop the development of hepatitis C drug valopicitabine. To read article click here.

Amgen Inc. to invest 6.5 billion to buyback stock. To read article click here.

-07/12/2007-

Ariad Pharmaceuticals and Merck & Co. form collaboration for the development of mTOR inhibitor AP23573l for cancer treatment. To read article click here.

Bristol-Myers Squibb and ImClone Systems Inc.'s Erbitux found ineffective in Phase III lung-cancer study. To read article click here.

-07/11/2007-

Press Release: Effortless liquid handling with sample management from Tecan. To read press release click here.

Press Release: NCE Discovery and Domainex merge to create a new drug discovery company. To read press release click here.

Press Release: IDBS renews participation in SAFE-BioPharma Association’s Vendor Partner Program. To read press release click here.

Amgen and Daiichi Sankyo Company Ltd. form collaboration for the development and commercialization of Denosumab in Japan. To read article click here.

-07/10/2007-

Press Release: Radleys have published a Technical Bulletin that describes a series of controlled heating tests comparing the heat-up times and energy consumption of its Heat-On™ heating blocks with another leading brand. To read press release click here.

Press Release: Applied Biosystems: Scientists Establish Essential Markers to Characterise Human Embryonic Stem Cell Lines. To read press release click here.

Press Release: Frost & Sullivan: Increasing Demand for Active Lifestyles and Non-surgical Treatment Options Drive European Osteoarthritis Market. To read press release click here.

Press Release: Activotec selected the recent 20th American Peptide Society Symposium in Montreal, Canada, for the North American launch of its Activo-P11 Peptide Synthesiser. To read press release click here.

Press Release: Available in black, white or clear polystyrene, Porvair Sciences offers a comprehensive range of 384-well assay plates optimised for fluorescence, luminescence / scintillation and ELISA / turbidity measurements. To read press release click here.

Tercica Inc. and Genentech Inc. sign alliance agreement for metabolic disorders. To read article click here.

Samaritan Pharmaceuticals Inc.'s Caprospinol's (SP-233) shows efficacy in decreasing beta amyloid plaque in the brain along with complete memory recovery. To read article click here.

-07/9/2007-

QIAGEN acquires eGene. To read article click here.

-07/6/2007-

Viragen Inc. to be delested from the American Stock Exchange (Amex). To read article click here.

-07/5/2007-

Press Release: SP Industries has announced that Genevac now provides European representation of its FTS SMART Freeze-Dryer™ Technology. To read press release click here.

Press Release: Guava Technologies Inc. has announced that it has been successfully audited to the requirements of ISO13485:2003 by BSI Management Systems. To read press release click here.

Genaera Corp. discontinues discontinued mid-stage studies of Squalamine for cystic fibrosis and prostate cancer treatment. To read article click here.

-07/3/2007-

FDA approves low dose of Roche's Tamiflu. To read article click here.

FDA revokes Altus Pharmaceuticals Inc.'s ALTU-135's orphan drug status for pancreatic insufficiency treatment. To read article click here.

-07/02/2007-

Press Release: Tecan and the Monash Antibody Technologies Facility join forces to produce the largest monoclonal antibody production facility in the Southern hemisphere. To read press release click here.

Press Release: Applied Biosystem: Scientists discover new role for microRNAs in stopping tumour cell growth. To read press release click here.

Abbott and Genentech Inc. form oncology research, development and commercialization collaboration for Abbott's ABT-263 and ABT-869. To read article click here.

Biogen Idec and Elan Corporation 's TYSABRI® (natalizumab) recommended for people with highly active relapsing remitting multiple sclerosis. To read article click here.

Biogen Idec Inc. and Cardiokine Inc. form alliance to develop hyponatremia drug for the treatment of congestive heart failure. To read article click here.

Genzyme Corporation reiterates its intention to acquire Bioenvision Inc. To read article click here.

Galapagos NV and GSK expand multi-year osteoarthritis alliance. To read article click here.

Novartis AG buys stake and strikes license deals with Intercell AG for about $363 million. To read article click here.

Albany Molecular Research Inc. buys two pharmaceutical manufacturing sites in India for $11 million in cash. To read article click here.